Literature DB >> 8098421

Complement resistance in Branhamella (Moraxella) catarrhalis.

C Hol, C M Verduin, E van Dijke, J Verhoef, H van Dijk.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8098421     DOI: 10.1016/0140-6736(93)91185-o

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.

Authors:  Franz-Josef Schmitz; Andreas Beeck; Mirella Perdikouli; Mechthild Boos; Susanne Mayer; Sybille Scheuring; Karl Köhrer; Jan Verhoef; Ad C Fluit
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  A UspA2H-negative variant of Moraxella catarrhalis strain O46E has a deletion in a homopolymeric nucleotide repeat common to uspA2H genes.

Authors:  Wei Wang; Melanie M Pearson; Ahmed S Attia; Robert J Blick; Eric J Hansen
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

3.  Phage antibodies obtained by competitive selection on complement-resistant Moraxella (Branhamella) catarrhalis recognize the high-molecular-weight outer membrane protein.

Authors:  E Boel; H Bootsma; J de Kruif; M Jansze; K L Klingman; H van Dijk; T Logtenberg
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

4.  Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method.

Authors:  C M Verduin; C Hol; E Van Dijke; J A Faber; M Jansze; J Verhoef; H Van Dijk
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

5.  The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.

Authors:  Ahmed S Attia; Eric R Lafontaine; Jo L Latimer; Christoph Aebi; George A Syrogiannopoulos; Eric J Hansen
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Lipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum.

Authors:  A Zaleski; N K Scheffler; P Densen; F K Lee; A A Campagnari; B W Gibson; M A Apicella
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope.

Authors:  J C McMichael; M J Fiske; R A Fredenburg; D N Chakravarti; K R VanDerMeid; V Barniak; J Caplan; E Bortell; S Baker; R Arumugham; D Chen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation.

Authors:  C M Verduin; M Jansze; C Hol; T E Mollnes; J Verhoef; H van Dijk
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant.

Authors:  Nicole R Luke; Simon Allen; Bradford W Gibson; Anthony A Campagnari
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade.

Authors:  Ahmed S Attia; Sanjay Ram; Peter A Rice; Eric J Hansen
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.